After Beating Cancer, Patient Experiences Treatment-Associated Memory Loss
Lisa Elliott, 34, an attorney who lives in Mason, says her world changed in December 2010.
At the age of 29, she was diagnosed with breast cancer.
"After a lumpectomy to remove the tumor, followed by radiation, I was prescribed Tamoxifen, she says. Tamoxifen is often prescribed to treat cancer and may also prevent it from recurring.
Elliott, who is the patient of Elyse Lower, MD, director of the Breast Cancer Center within the UC Cancer Institute, says life continued as normal for the most part, until about a year and a half ago when she began experiencing a slip in her memory.
"I noticed I wasnt thinking clearly, she says. "I felt very distracted, which has continued to today. For example, Ill be in the middle of telling a friend a story, and shell look at me and say, You just told me that yesterday, and Ill have no recollection of doing so.
"Its become comical to us.
Elliott says shes never experienced forgetfulness that could be dangerous, but she has definitely noticed a change in her cognitive ability and focus.
"I do think that it has to do with my cancer treatment, she says. "However, I wouldnt trade being cancer free for anything.
Now, the UC Cancer and Neuroscience Institutes are holding a free interactive seminar for people like Elliott to learn more about reasons cancer therapy can cause memory loss and other cognitive issues. The event will take place from 9 a.m. to noon Saturday, Sept. 12, at the Kingsgate Marriott Conference Center.
In addition to presentations by experts, there will also be interactive breakout sessions and a Q&A.
cancer and memory
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.